IIROC Trade Resumption - PILL /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:0in; } Canada NewsWire VANCOUVER, Nov. 20, 2019 VANCOUVER, Nov. 20, 2019 /CNW/ - Trading resumes in: Company: Canntab Therapeutics Limited CSE Symbol: PILL (all issues) Resumption (ET): 12:45 IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada. SOURCE Investment Industry Regulatory Organization of Canada (IIROC) View original content: http://www.newswire.ca/en/releases/archive/November2019/20/c1730.html For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (http://www.iiroc.ca/industry/marketmonitoringanalysis/Pages/Trading-Halts-Timely-Disclosure.aspx) at www.iiroc.ca under the Halts & Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints & Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.Copyright CNW Group 2019Canada NewswireNovember 20, 2019 - 9:27 AM PSTNews by QuoteMediawww.quotemedia.com